Division of Gastroenterology and Hepatology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Clin Mol Hepatol. 2023 Apr;29(2):197-205. doi: 10.3350/cmh.2022.0404. Epub 2023 Jan 5.
Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean Liver Cancer Association and National Cancer Center Korea Practice Guideline Revision Committee have recently revised the practice guidelines for HCC management. However, there are some differences between practice guidelines and real-life clinical practice. In this review, we describe some key recommendations of the 2022 version of practice guidelines and the real-life clinical situation in South Korea, together with discussion about efforts needed to reduce the difference between guidelines and real-life clinical practice.
肝细胞癌（HCC）是许多国家（包括韩国）的主要死亡原因。为了为 HCC 患者的临床管理提供有用且合理的建议，韩国肝癌协会和韩国国家癌症中心实践指南修订委员会最近修订了 HCC 管理实践指南。然而，实践指南和现实临床实践之间存在一些差异。在这篇综述中，我们描述了 2022 年版实践指南的一些关键建议以及韩国的现实临床情况，并讨论了缩小指南与现实临床实践之间差距所需的努力。
